Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

CAR-T ICU 2019 | How could CAR-T affect transplantation in R/R lymphomas?

Robin Sanderson • 10 Jul 2019
CAR-T ICU 2019
Lymphoma CAR-T

Robin Sanderson, MBBS, PhD, King’s College Hospital NHS Foundation Trust, London, UK, discusses the current use of CAR T-cell therapy in relapsed/refractory lymphoma and whether this will have an impact on the practice of stem cell transplantation. This interview took place at the CAR-T Cell Therapy and the ICU meeting in London, UK, which was organized by EuroCARTForce.

More from Robin Sanderson

Lymphoma Sessions: CAR-T and lymphoma treatment in the UK
Robin Sanderson et al. • 18 May 2022
CAR T-cell therapy at King’s College Hospital 0:34
CAR T-cell therapy at King’s College Hospital
Robin Sanderson • 30 Jan 2020
The CAR T-cell therapy referral pathway at King’s College London 1:00
The CAR T-cell therapy referral pathway at King’s College London
Robin Sanderson • 30 Jan 2020
Exciting data from the 2nd European CAR T-Cell Meeting 0:56
Exciting data from the 2nd European CAR T-Cell Meeting
Robin Sanderson • 30 Jan 2020

Related Videos

Long-term follow-up results from ELM-2: odronextamab in R/R FL 8:08
Long-term follow-up results from ELM-2: odronextamab in R/R FL
Gottfried von Keudell • 18 Sep 2025
The efficacy of glofitamab in patients with heavily pre-treated R/R MCL 1:24
The efficacy of glofitamab in patients with heavily pre-treated R/R MCL
Tycel Phillips • 5 Sep 2025
Bringing clinical trials to the community: current approaches at Sarah Cannon Research Institute 1:01
Bringing clinical trials to the community: current approaches at Sarah Cannon Research Institute
Krish Patel • 4 Sep 2025
Bispecifics and CAR T-cell therapy in lymphoma: sequencing strategies and considerations 1:52
Bispecifics and CAR T-cell therapy in lymphoma: sequencing strategies and considerations
Tycel Phillips • 5 Sep 2025
The content of VJHemOnc is intended for healthcare professionals